Effects of 14 F9 synonymous codon variants on hemophilia B expression: Alteration of splicing along with protein expression

Hum Mutat. 2022 Jul;43(7):928-939. doi: 10.1002/humu.24377. Epub 2022 Apr 19.

Abstract

There is growing evidence that synonymous codon variants (SCVs) can cause disease through the disruption of different processes of protein production. The aim of the study is to investigate whether the 14 SCVs reported in the F9 variant database were the pathogenic causes of hemophilia B. The impacts of SCVs on splicing and protein expression were detected using a combination of in silico prediction, in vitro minigene splicing assay and cell expression detection. The splicing transcripts were identified and quantified by co-amplification fluorescent PCR. The mechanism of splicing was verified by a modified pU1snRNA and pU7snRNA approach. Aberrant splicing patterns were found in eight SCVs. Five of the 8 SCVs produced almost all aberrant splicing isoforms, which were expected to truncate protein, three of them presented a partial defect on both splicing and protein secretion, the overall effects were consistent with the residual Factor IX activity of the affected cases. Neither the pre-messenger RNA (mRNA) splicing process nor the protein function was impaired in the rest six SCVs. In conclusion, our study firstly revealed the pathogenic mechanism of the 14 F9 SCVs and highlighted the importance of performing mRNA splicing analysis and protein expression studies of SCVs in inherited disorders.

Keywords: gene expression; hemophilia B; minigene assay; regulatory elements; synonymous codon variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Codon
  • Factor IX / genetics*
  • Hemophilia B* / genetics
  • Humans
  • RNA Splicing* / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Silent Mutation*

Substances

  • Codon
  • RNA, Messenger
  • Factor IX